Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 69   

Articles published

GSK 1,566.00 +15.00 (0.97%)
price chart
Hikma Beats GSK, Pfizer In Argatroban IP Infringement Row
Law360, New York (July 31, 2012, 7:17 PM ET) -- GlaxoSmithKline PLC and Pfizer Inc. on Tuesday failed to stop Hikma Pharmaceutical Co.
Glaxo to Pay $3 Billion for Human Genome
July 16 (Bloomberg) -- GlaxoSmithKline Plc agreed to buy Human Genome Sciences Inc. for $3 billion in cash, winning control of its U.S.
Glaxo to Buy Human Genome  Wall Street Journal
GlaxoSmithKline to acquire Human Genome Sciences  Baltimore Sun (blog)
Related articles »  
Glaxo in $3 Billion Settlement
Drug maker GlaxoSmithKline PLC agreed to plead guilty to criminal charges of illegally marketing drugs and withholding safety data from U.S.
Glaxo Pleads Guilty, Fined $1 Billion in Drug-Marketing Case  Bloomberg
Record fine for UK drug company over fraud  FRANCE 24
Related articles »  
Stocks That Avoid Unrecoverable Foreign Dividend Withholding In Tax Deferred ...
While we cannot be entirely certain, it appears that BHP (the Australian ADR for BHP Billiton plc) is partially franked. However, since the other BHP Billiton plc ADR (BBL) is U.K. based, paying a higher net yield (not subject to dividend tax ...
SEC filing: GlaxoSmithKline makes clean sweep of Human Genome Sciences ...
Glaxo's Adrian Rawcliffe has been appointed Human Genome Sciences' chief financial officer, replacing David Southwell, and GSK General Counsel Daniel Troy has replaced James Davis as secretary of Human Genome. All but three of HGS' directors have ...
Related articles »  
Big Pharma is in big trouble � or should be
Something is definitely wrong in their management and monitoring systems. GSK are not able to say that the activities for which they were fined were anything other than deliberate.
Related articles »  
GlaxoSmithKline pays US$3-billion to settle biggest healthcare fraud case in ...
WASHINGTON - GlaxoSmithKline Plc has agreed to plead guilty to misdemeanor criminal charges and pay US$3 billion to settle the largest case of healthcare fraud in U.S.
Glaxo Agrees to Misdemeanor Plea, Will Pay $3B in Record Health Care Fraud ...  ABA Journal
GlaxoSmithKline to pay $3B in healthcare fraud  Emirates 24/7
Related articles »  
Glaxo Executives Cited in Case Now Lead Sanofi, Actelion
July 4 (Bloomberg) -- Two senior executives at GlaxoSmithKline Plc singled out by the U.S. Justice Department for pushing the Advair asthma drug for unapproved uses have moved on to some of Europe's top pharmaceutical companies.
Related articles »  
Glaxo Tries to Shake Marketing Questions on Advair
According to the U.S. government, from 2001 through "at least 2010," Glaxo used illegal marketing tactics to promote Advair, an inhaler licensed to treat moderate to severe forms of asthma.
Related articles »  
3 U.K. Stocks With U.S.-Style Dividends And No Tax Withholding For A Dividend ...
B), GlaxoSmithKline PLC (GSK), and HSBC Holdings PLC (HBC). Royal Dutch Shell PLC Class B - This company is one of the largest integrated oil companies in the world, having a market capitalization of $228 billion.